{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:05Z","timestamp":1792782605294,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad de la Rioja","id":[{"id":"https:\/\/ror.org\/0553yr311","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Cefiderocol is a newly developed siderophore-conjugated cephalosporin specifically designed to overcome multidrug-resistant (MDR) Gram-negative bacilli. Nevertheless, reduced susceptibility and resistance to cefiderocol has increasingly been reported, especially derived from alterations in iron transport systems and plasmid-mediated determinants and the expression of structural variants of \u03b2-lactamases. Moreover, cefiderocol resistance derived from target alteration remains insufficiently defined. This work aimed to characterize the genomic and structural basis of cefiderocol resistance emerging in vivo during therapy in\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      . Comparative genomics revealed conserved plasmid architecture and no acquisition of novel \u03b2-lactamases or iron-uptake determinants. Eighty-two chromosomal variants were identified, among which a missense substitution in ftsI (FtsI G306V), located adjacent to the catalytic serine (S307) of PBP3, emerged as a plausible resistance determinant. Structural modelling suggests that the G306V substitution introduces a significant side-chain volumetric increase, resulting in locally increased steric hindrance within the active-site, possibly impairing cefiderocol interaction with its target. The absence of canonical iron-transport alterations further distinguishes this case from the predominant mechanism described in global molecular epidemiology studies. Large-scale genomic screening revealed a very low prevalence of substitutions affecting\n                      <jats:italic>ftsI,<\/jats:italic>\n                      including in resistance isolates, although possible clonal expansion cannot be ruled out. Our findings align with the broader epidemiological landscape in which cefiderocol resistance is heterogeneous and flexible. Therefore, incorporating analysis of\n                      <jats:italic>ftsI<\/jats:italic>\n                      variants within or proximal to the active-site into genomic surveillance frameworks could improve resistance detection to this last-resort antibiotic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key points<\/jats:title>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>Resistance occurred without alterations in iron-uptake systems or siderophore pathways.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>Mutations in FtsI (G306V) and AcrR (E91K) were identified as key candidates.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>FtsI G306V is rare across cefiderocol resistant and global K. pneumoniae genomes.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00253-026-13967-y","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:25:11Z","timestamp":1784928311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic and structural insights into the in vivo development of cefiderocol resistance in Klebsiella pneumoniae"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-4414","authenticated-orcid":false,"given":"Alexander","family":"Tristancho-Bar\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-5418","authenticated-orcid":false,"given":"Ana Isabel","family":"L\u00f3pez-Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-8952","authenticated-orcid":false,"given":"Ana","family":"Milagro-Beamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Fortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Garc\u00eda-Lechuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-5672","authenticated-orcid":false,"given":"Rosa","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5162-4641","authenticated-orcid":false,"given":"Ruth","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-0124","authenticated-orcid":false,"given":"Miriam","family":"Latorre-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-2331","authenticated-orcid":false,"given":"Laura","family":"Clusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Buzg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-1690","authenticated-orcid":false,"given":"Carmen","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-245X","authenticated-orcid":false,"given":"Antonio","family":"Rezusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"13967_CR1","doi-asserted-by":"publisher","first-page":"13339","DOI":"10.1073\/pnas.0606167103","volume":"103","author":"A Addlagatta","year":"2006","unstructured":"Addlagatta A, Gay L, Matthews BW (2006) Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site. Proc Natl Acad Sci U S A 103:13339\u201313344. https:\/\/doi.org\/10.1073\/pnas.0606167103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13967_CR2","doi-asserted-by":"publisher","first-page":"D690","DOI":"10.1093\/nar\/gkac920","volume":"51","author":"BP Alcock","year":"2023","unstructured":"Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, Edalatmand A, Petkau A, Syed SA, Tsang KK, Baker SJC, Dave M, McCarthy MC, Mukiri KM, Nasir JA, Golbon B, Imtiaz H, Jiang X, Kaur K, Kwong M, Liang ZC, Niu KC, Shan P, Yang JYJ, Gray KL, Hoad GR, Jia B, Bhando T, Carfrae LA, Farha MA, French S, Gordzevich R, Rachwalski K, Tu MM, Bordeleau E, Dooley D, Griffiths E, Zubyk HL, Brown ED, Maguire F, Beiko RG, Hsiao WWL, Brinkman FSL, Van Domselaar G, McArthur AG (2023) CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Res 51:D690\u2013D699. https:\/\/doi.org\/10.1093\/nar\/gkac920","journal-title":"Nucleic Acids Res"},{"key":"13967_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116372","volume":"110","author":"S Amadesi","year":"2024","unstructured":"Amadesi S, Amedeo A, Rinaldi M, Palombo M, Giannella M, Gaibani P (2024a) In vivo emergence of cefiderocol and ceftazidime\/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime\/avibactam -based therapies. Diagn Microbiol Infect Dis 110:116372. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116372","journal-title":"Diagn Microbiol Infect Dis"},{"key":"13967_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107107","volume":"63","author":"S Amadesi","year":"2024","unstructured":"Amadesi S, Gatti M, Rinaldi M, Pea F, Viale P, Gaibani P (2024b) Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime\/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime\/avibactam treatment. Int J Antimicrob Agents 63:107107. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107107","journal-title":"Int J Antimicrob Agents"},{"key":"13967_CR5","unstructured":"Andrews S (2010) FastQC: A Quality Control tool for High Throughput Sequence Data. Babraham Bioinformatics, Cambridge, UK"},{"key":"13967_CR6","doi-asserted-by":"publisher","unstructured":"Bianco G, Boattini M, Cricca M, Diella L, Gatti M, Rossi L, Bartoletti M, Sambri V, Signoretto C, Fonnesu R, Comini S, Gaibani P (2024) Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol. CIMB 46:14132\u201314153. https:\/\/doi.org\/10.3390\/cimb46120846","DOI":"10.3390\/cimb46120846"},{"key":"13967_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"13967_CR8","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.001244","author":"G Bouras","year":"2024","unstructured":"Bouras G, Houtak G, Wick RR, Mallawaarachchi V, Roach MJ, Papudeshi B, Judd LM, Sheppard AE, Edwards RA, Vreugde S (2024) Hybracter: enabling scalable, automated, complete and accurate bacterial genome assemblies. Microb Genom. https:\/\/doi.org\/10.1099\/mgen.0.001244","journal-title":"Microb Genom"},{"key":"13967_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad409","volume":"39","author":"G Bouras","year":"2023","unstructured":"Bouras G, Sheppard AE, Mallawaarachchi V, Vreugde S (2023) Plassembler: an automated bacterial plasmid assembly tool. Bioinformatics 39:btad409. https:\/\/doi.org\/10.1093\/bioinformatics\/btad409","journal-title":"Bioinformatics"},{"key":"13967_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050475","volume":"14","author":"L Buzg\u00f3","year":"2025","unstructured":"Buzg\u00f3 L, Kiss Z, G\u00f6bhardter D, Lesinszki V, Ungv\u00e1ri E, R\u00e1dai Z, Laczk\u00f3 L, Damjanova I, Kardos G, T\u00f3th \u00c1 (2025) High prevalence of cefiderocol resistance among New Delhi metallo-\u03b2-lactamase producing Klebsiella pneumoniae high-risk clones in Hungary. Antibiotics (Basel) 14:475. https:\/\/doi.org\/10.3390\/antibiotics14050475","journal-title":"Antibiotics (Basel)"},{"key":"13967_CR11","doi-asserted-by":"publisher","first-page":"e02776","DOI":"10.1128\/spectrum.02776-23","volume":"12","author":"JA Castillo-Polo","year":"2024","unstructured":"Castillo-Polo JA, Hern\u00e1ndez-Garc\u00eda M, Maruri-Aransolo A, De La Vega C, Ruiz-Garbajosa P, Cant\u00f3n R (2024) Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1- Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping. Microbiol Spectr 12:e02776-e2823. https:\/\/doi.org\/10.1128\/spectrum.02776-23","journal-title":"Microbiol Spectr"},{"key":"13967_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1680292","volume":"13","author":"J Chen","year":"2025","unstructured":"Chen J, Hou Y, Shi J, Gao X, Liang G (2025) Mortality risk of carbapenem-resistant hypervirulent Klebsiella pneumoniae vs. classical CR-KP: a systematic review and meta-analysis. Front Public Health 13:1680292. https:\/\/doi.org\/10.3389\/fpubh.2025.1680292","journal-title":"Front Public Health"},{"key":"13967_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6:80\u201392. https:\/\/doi.org\/10.4161\/fly.19695","journal-title":"Fly (Austin)"},{"key":"13967_CR14","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.43.2200795","author":"M Coppi","year":"2022","unstructured":"Coppi M, Antonelli A, Niccolai C, Bartolini A, Bartolini L, Grazzini M, Mantengoli E, Farese A, Pieralli F, Mechi MT, Di Pilato V, Giani T, Rossolini GM (2022) Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.43.2200795","journal-title":"Euro Surveill"},{"key":"13967_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad311","volume":"39","author":"W De Coster","year":"2023","unstructured":"De Coster W, Rademakers R (2023) NanoPack2: population-scale evaluation of long-read sequencing data. Bioinformatics 39:btad311. https:\/\/doi.org\/10.1093\/bioinformatics\/btad311","journal-title":"Bioinformatics"},{"key":"13967_CR16","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1093\/bioinformatics\/btz184","volume":"35","author":"J Delgado","year":"2019","unstructured":"Delgado J, Radusky LG, Cianferoni D, Serrano L (2019) FoldX 5.0: working with RNA, small molecules and a new graphical interface. Bioinformatics 35:4168\u20134169. https:\/\/doi.org\/10.1093\/bioinformatics\/btz184","journal-title":"Bioinformatics"},{"key":"13967_CR17","doi-asserted-by":"publisher","first-page":"e04936","DOI":"10.1128\/spectrum.04936-22","volume":"11","author":"M Delgado-Valverde","year":"2023","unstructured":"Delgado-Valverde M, Portillo-Calder\u00f3n I, Recacha E, P\u00e9rez-Palacios P, Pascual A (2023) In vitro activity of cefiderocol compared to other antimicrobials against a collection of metallo-beta-lactamase-producing gram-negative bacilli from southern Spain. Microbiol Spectr 11:e04936-e5022. https:\/\/doi.org\/10.1128\/spectrum.04936-22","journal-title":"Microbiol Spectr"},{"key":"13967_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107321","volume":"151","author":"L Deroche","year":"2025","unstructured":"Deroche L, Rozenholc A, Arriv\u00e9 F, Martellosio J-P, Moal GL, Thille AW, Barraud O, Marchand S, Buyck JM (2025) Emergence of cefiderocol resistance during therapy in NDM-5\u2013producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations. Int J Infect Dis 151:107321. https:\/\/doi.org\/10.1016\/j.ijid.2024.107321","journal-title":"Int J Infect Dis"},{"key":"13967_CR19","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2025) Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. https:\/\/www.eucast.org"},{"key":"13967_CR20","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"13967_CR21","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1021\/acschembio.2c00503","volume":"17","author":"PL Flanders","year":"2022","unstructured":"Flanders PL, Contreras-Martel C, Brown NW, Shirley JD, Martins A, Nauta KN, Dessen A, Carlson EE, Ambrose EA (2022) Combined structural analysis and molecular dynamics reveal penicillin-binding protein inhibition mode with \u03b2-lactones. ACS Chem Biol 17:3110\u20133120. https:\/\/doi.org\/10.1021\/acschembio.2c00503","journal-title":"ACS Chem Biol"},{"key":"13967_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ (2016) Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 11:905\u2013919. https:\/\/doi.org\/10.1038\/nprot.2016.051","journal-title":"Nat Protoc"},{"key":"13967_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01507-23","volume":"68","author":"JA Freiberg","year":"2024","unstructured":"Freiberg JA, Tao L, Manuel C, Mike LA, Nelson GE, Harris BD, Mathers AJ, Talbot TR, Skaar EP, Humphries RM (2024) A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance. Antimicrob Agents Chemother 68:e01507-23. https:\/\/doi.org\/10.1128\/aac.01507-23","journal-title":"Antimicrob Agents Chemother"},{"key":"13967_CR24","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/jac\/dkac221","volume":"2022","author":"C Fr\u00f6hlich","year":"2022","unstructured":"Fr\u00f6hlich C, S\u00f8rum V, Tokuriki N, Johnsen PJ, Samuelsen \u00d8 (2022) Evolution of \u03b2-lactamase-mediated cefiderocol resistance. J Antimicrob Chemother 2022:2429\u20132436. https:\/\/doi.org\/10.1093\/jac\/dkac221","journal-title":"J Antimicrob Chemother"},{"key":"13967_CR25","doi-asserted-by":"publisher","first-page":"31312","DOI":"10.1038\/s41598-025-17044-8","volume":"15","author":"S Hanna","year":"2025","unstructured":"Hanna S, La K, Yoshii Y, Gits-Muselli M, El Meouche I, Benhadid-brahmi Y, Bonacorsi S, Birgy A (2025) Exploring mutational possibilities of KPC variants to reach high level resistance to cefiderocol. Sci Rep 15:31312. https:\/\/doi.org\/10.1038\/s41598-025-17044-8","journal-title":"Sci Rep"},{"key":"13967_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/molbev\/msx281","volume":"35","author":"DT Hoang","year":"2018","unstructured":"Hoang DT, Chernomor O, Von Haeseler A, Minh BQ, Vinh LS (2018) UFBoot2: improving the ultrafast bootstrap approximation. Mol Biol Evol 35:518\u2013522. https:\/\/doi.org\/10.1093\/molbev\/msx281","journal-title":"Mol Biol Evol"},{"key":"13967_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01454-17","volume":"62","author":"A Ito","year":"2018","unstructured":"Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y (2018) In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacteria. Antimicrob Agents Chemother 62:e01454-17. https:\/\/doi.org\/10.1128\/AAC.01454-17","journal-title":"Antimicrob Agents Chemother"},{"key":"13967_CR28","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-018-07641-9","volume":"9","author":"C Jain","year":"2018","unstructured":"Jain C, Rodriguez-R LM, Phillippy AM, Konstantinidis KT, Aluru S (2018) High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun 9:5114. https:\/\/doi.org\/10.1038\/s41467-018-07641-9","journal-title":"Nat Commun"},{"key":"13967_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/antibiotics11060723","volume":"11","author":"S Karakonstantis","year":"2022","unstructured":"Karakonstantis S, Rousaki M, Kritsotakis EI (2022) Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics (Basel) 11:723. https:\/\/doi.org\/10.3390\/antibiotics11060723","journal-title":"Antibiotics (Basel)"},{"key":"13967_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM (2013) MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30:772\u2013780. https:\/\/doi.org\/10.1093\/molbev\/mst010","journal-title":"Mol Biol Evol"},{"key":"13967_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae311","volume":"40","author":"B Kille","year":"2024","unstructured":"Kille B, Nute MG, Huang V, Kim E, Phillippy AM, Treangen TJ (2024) Parsnp 2.0: scalable core-genome alignment for massive microbial datasets. Bioinformatics 40:btae311. https:\/\/doi.org\/10.1093\/bioinformatics\/btae311","journal-title":"Bioinformatics"},{"key":"13967_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciab511","volume":"74","author":"S Klein","year":"2022","unstructured":"Klein S, Boutin S, Kocer K, Fiedler MO, St\u00f6rzinger D, Weigand MA, Tan B, Richter D, Rupp C, Mieth M, Mehrabi A, Hackert T, Zimmermann S, Heeg K, Nurjadi D (2022) Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA. Clin Infect Dis 74:905\u2013908. https:\/\/doi.org\/10.1093\/cid\/ciab511","journal-title":"Clin Infect Dis"},{"key":"13967_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41429-024-00762-y","volume":"77","author":"R Kriz","year":"2024","unstructured":"Kriz R, Spettel K, Pichler A, Schefberger K, Sanz-Codina M, L\u00f6tsch F, Harrison N, Willinger B, Zeitlinger M, Burgmann H, Lagler H (2024) In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol. J Antibiot 77:757\u2013767. https:\/\/doi.org\/10.1038\/s41429-024-00762-y","journal-title":"J Antibiot"},{"key":"13967_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24448-3","volume":"12","author":"MMC Lam","year":"2021","unstructured":"Lam MMC, Wick RR, Watts SC, Cerdeira LT, Wyres KL, Holt KE (2021) A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun 12:4188. https:\/\/doi.org\/10.1038\/s41467-021-24448-3","journal-title":"Nat Commun"},{"key":"13967_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106646","volume":"60","author":"P Lan","year":"2022","unstructured":"Lan P, Lu Y, Jiang Y, Wu X, Yu Y, Zhou J (2022) Catecholate siderophore receptor CirA impacts cefiderocol susceptibility in Klebsiella pneumoniae. Int J Antimicrob Agents 60:106646. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106646","journal-title":"Int J Antimicrob Agents"},{"key":"13967_CR36","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic I, Bork P (2024) Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res 52:W78\u2013W82. https:\/\/doi.org\/10.1093\/nar\/gkae268","journal-title":"Nucleic Acids Res"},{"key":"13967_CR37","doi-asserted-by":"publisher","first-page":"e01410","DOI":"10.1128\/spectrum.01410-24","volume":"13","author":"H Long","year":"2025","unstructured":"Long H, Feng Y, Zong Z (2025) Global molecular epidemiology of the incomplete CirA protein related to cefiderocol resistance in Klebsiella pneumoniae\u202f: a genome-based study. Microbiol Spectr 13:e01410-e1424. https:\/\/doi.org\/10.1128\/spectrum.01410-24","journal-title":"Microbiol Spectr"},{"key":"13967_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14080832","volume":"14","author":"I Luu","year":"2025","unstructured":"Luu I, Mezcord V, Escalante J, Traglia GM, Tuttobene MR, Rodriguez C, Cheng CF, Valle Q, Sharma R, Tolmasky ME, Bonomo RA, Rao G, Pasteran F, Ramirez MS (2025) Spontaneous emergence of cefiderocol resistance in Klebsiella pneumoniae KPC-163: genomic and transcriptomic insights. Antibiotics (Basel) 14:832. https:\/\/doi.org\/10.3390\/antibiotics14080832","journal-title":"Antibiotics (Basel)"},{"key":"13967_CR39","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.1093\/nar\/gkh435","volume":"32","author":"S McGinnis","year":"2004","unstructured":"McGinnis S, Madden TL (2004) BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 32:W20\u2013W25. https:\/\/doi.org\/10.1093\/nar\/gkh435","journal-title":"Nucleic Acids Res"},{"key":"13967_CR40","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, Von Haeseler A, Lanfear R (2020) IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 37:1530\u20131534. https:\/\/doi.org\/10.1093\/molbev\/msaa015","journal-title":"Mol Biol Evol"},{"key":"13967_CR41","doi-asserted-by":"publisher","first-page":"e03496","DOI":"10.1128\/spectrum.03496-22","volume":"11","author":"SH Moon","year":"2023","unstructured":"Moon SH, Huang E (2023) Cefiderocol resistance in Klebsiella pneumoniae is linked to shv extended-spectrum \u03b2-lactamase activities and functional loss of the outer membrane porin OmpK35. Microbiol Spectr 11:e03496-e3522. https:\/\/doi.org\/10.1128\/spectrum.03496-22","journal-title":"Microbiol Spectr"},{"key":"13967_CR42","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/mdr.2021.0180","volume":"28","author":"P Nordmann","year":"2022","unstructured":"Nordmann P, Shields RK, Doi Y, Takemura M, Echols R, Matsunaga Y, Yamano Y (2022) Mechanisms of reduced susceptibility to cefiderocol among isolates from the CREDIBLE-CR and APEKS-NP clinical trials. Microb Drug Resist 28:398\u2013407. https:\/\/doi.org\/10.1089\/mdr.2021.0180","journal-title":"Microb Drug Resist"},{"key":"13967_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"13967_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13059-019-1841-x","volume":"20","author":"BD Ondov","year":"2019","unstructured":"Ondov BD, Starrett GJ, Sappington A, Kostic A, Koren S, Buck CB, Phillippy AM (2019) Mash screen: high-throughput sequence containment estimation for genome discovery. Genome Biol 20:232. https:\/\/doi.org\/10.1186\/s13059-019-1841-x","journal-title":"Genome Biol"},{"key":"13967_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13059-021-02393-0","volume":"22","author":"A Orakov","year":"2021","unstructured":"Orakov A, Fullam A, Coelho LP, Khedkar S, Szklarczyk D, Mende DR, Schmidt TSB, Bork P (2021) GUNC: detection of chimerism and contamination in prokaryotic genomes. Genome Biol 22:178. https:\/\/doi.org\/10.1186\/s13059-021-02393-0","journal-title":"Genome Biol"},{"key":"13967_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1570278","volume":"16","author":"F Pasteran","year":"2025","unstructured":"Pasteran F, Manuel De Mendieta J, Pujato N, Dotta G, Gonz\u00e1lez LJ, Rizzo M, Fern\u00e1ndez A, Ceriana P, Maccari L, Rapoport M, G\u00f3mez S, Lucero C, Menocal MA, Albornoz E, De Belder D, Radisic M, Vila AJ, Corso A (2025) From genomics to treatment: overcoming pan-drug-resistant Klebsiella pneumoniae in clinical settings. Front Pharmacol 16:1570278. https:\/\/doi.org\/10.3389\/fphar.2025.1570278","journal-title":"Front Pharmacol"},{"key":"13967_CR47","doi-asserted-by":"publisher","DOI":"10.3201\/eid3101.241426","author":"R Polani","year":"2025","unstructured":"Polani R, De Francesco A, Tomolillo D, Artuso I, Equestre M, Trirocco R, Arcari G, Antonelli G, Villa L, Prosseda G, Visca P, Carattoli A (2025) Cefiderocol resistance conferred by plasmid-located ferric citrate transport system in Klebsiella pneumoniae carbapenemase \u2013 producing K. pneumoniae. Emerg Infect Dis. https:\/\/doi.org\/10.3201\/eid3101.241426","journal-title":"Emerg Infect Dis"},{"key":"13967_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","volume":"29","author":"RF Potter","year":"2016","unstructured":"Potter RF, D\u2019Souza AW, Dantas G (2016) The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat 29:30\u201346. https:\/\/doi.org\/10.1016\/j.drup.2016.09.002","journal-title":"Drug Resist Updat"},{"key":"13967_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2025.168999","volume":"437","author":"M Radojkovi\u0107","year":"2025","unstructured":"Radojkovi\u0107 M, Bruggeling Van Ingen A, Timmer M, Ubbink M (2025) Stabilizing mutations enhance evolvability of BlaC \u03b2-lactamase by widening the mutational landscape. J Mol Biol 437:168999. https:\/\/doi.org\/10.1016\/j.jmb.2025.168999","journal-title":"J Mol Biol"},{"key":"13967_CR50","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1021\/acscatal.1c05524","volume":"12","author":"AJ Robertson","year":"2022","unstructured":"Robertson AJ, Cruz-Navarrete FA, Wood HP, Vekaria N, Hounslow AM, Bisson C, Cliff MJ, Baxter NJ, Waltho JP (2022) An enzyme with high catalytic proficiency utilizes distal site substrate binding energy to stabilize the closed state but at the expense of substrate inhibition. ACS Catal 12:3149\u20133164. https:\/\/doi.org\/10.1021\/acscatal.1c05524","journal-title":"ACS Catal"},{"key":"13967_CR51","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000206","author":"J Robertson","year":"2018","unstructured":"Robertson J, Nash JHE (2018) MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies. Microb Genom. https:\/\/doi.org\/10.1099\/mgen.0.000206","journal-title":"Microb Genom"},{"key":"13967_CR52","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1093\/cid\/ciz826","volume":"69","author":"T Sato","year":"2019","unstructured":"Sato T, Yamawaki K (2019) Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis 69:S538\u2013S543. https:\/\/doi.org\/10.1093\/cid\/ciz826","journal-title":"Clin Infect Dis"},{"key":"13967_CR53","unstructured":"Seemann T Snippy: Rapid haploid variant calling and core genome alignment (Seemann https:\/\/github.com\/tseemann\/snippy) accessed 15 Oct 2025"},{"key":"13967_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2271096","volume":"12","author":"K Schaufler","year":"2023","unstructured":"Schaufler K, Echelmeyer T, Schwabe M, Guenther S, Bohnert JA, Becker K, Fickenscher H, Bueter A, Maschkowitz G, Krumbholz A, Nurjadi D, Heiden SE, Eger E (2023) Convergent Klebsiella pneumoniae strains belonging to a sequence type 307 outbreak clone combine cefiderocol and carbapenem resistance with hypervirulence. Emerg Microbes Infect 12:2271096. https:\/\/doi.org\/10.1080\/22221751.2023.2271096","journal-title":"Emerg Microbes Infect"},{"key":"13967_CR55","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000685","author":"O Schwengers","year":"2021","unstructured":"Schwengers O, Jelonek L, Dieckmann MA, Beyvers S, Blom J, Goesmann A (2021) Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification: find out more about Bakta, the motivation, challenges and applications, here. Microb Genom. https:\/\/doi.org\/10.1099\/mgen.0.000685","journal-title":"Microb Genom"},{"key":"13967_CR56","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L (2005) The FoldX web server: an online force field. Nucleic Acids Res 33:W382\u2013W388. https:\/\/doi.org\/10.1093\/nar\/gki387","journal-title":"Nucleic Acids Res"},{"key":"13967_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/cid\/ciab888","volume":"75","author":"PJ Simner","year":"2022","unstructured":"Simner PJ, Mostafa HH, Bergman Y, Ante M, Tekle T, Adebayo A, Beisken S, Dzintars K, Tamma PD (2022) Progressive development of cefiderocol resistance in Escherichia coli during therapy is associated with an increase in blaNDM-5 copy number and gene expression. Clin Infect Dis 75:47\u201354. https:\/\/doi.org\/10.1093\/cid\/ciab888","journal-title":"Clin Infect Dis"},{"key":"13967_CR58","doi-asserted-by":"publisher","first-page":"16928","DOI":"10.1039\/D4SC04937C","volume":"15","author":"HG Smith","year":"2024","unstructured":"Smith HG, Basak S, Aniebok V, Beech MJ, Alshref FM, Allen MD, Farley AJM, Schofield CJ (2024) Structural basis of Pseudomonas aeruginosa penicillin binding protein 3 inhibition by the siderophore-antibiotic cefiderocol. Chem Sci 15:16928\u201316937. https:\/\/doi.org\/10.1039\/D4SC04937C","journal-title":"Chem Sci"},{"key":"13967_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cmi.2023.11.005","volume":"30","author":"C Tascini","year":"2024","unstructured":"Tascini C, Coppi M, Antonelli A, Niccolai C, Bartolini A, Pecori D, Sartor A, Giani T, Rossolini GM (2024) In vivo evolution to high-level cefiderocol resistance of NDM-1\u2013producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission. Clin Microbiol Infect 30:398\u2013400. https:\/\/doi.org\/10.1016\/j.cmi.2023.11.005","journal-title":"Clin Microbiol Infect"},{"key":"13967_CR60","doi-asserted-by":"publisher","first-page":"D516","DOI":"10.1093\/nar\/gkae987","volume":"53","author":"F Tegenfeldt","year":"2025","unstructured":"Tegenfeldt F, Kuznetsov D, Manni M, Berkeley M, Zdobnov EM, Kriventseva EV (2025) Orthodb and BUSCO update: annotation of orthologs with wider sampling of genomes. Nucleic Acids Res 53:D516\u2013D522. https:\/\/doi.org\/10.1093\/nar\/gkae987","journal-title":"Nucleic Acids Res"},{"key":"13967_CR61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/antibiotics14010042","volume":"14","author":"A Tristancho-Bar\u00f3","year":"2025","unstructured":"Tristancho-Bar\u00f3 A, Franco-Fobe LE, Ariza MP, Milagro A, L\u00f3pez-Calleja AI, Fortu\u00f1o B, L\u00f3pez C, Latorre-Mill\u00e1n M, Clusa L, Mart\u00ednez R, Torres C, Rezusta A (2025a) Genomic characterization of carbapenemase-producing enterobacteriaceae from clinical and epidemiological human samples. Antibiotics (Basel) 14:42. https:\/\/doi.org\/10.3390\/antibiotics14010042","journal-title":"Antibiotics (Basel)"},{"key":"13967_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/antibiotics14070703","volume":"14","author":"A Tristancho-Bar\u00f3","year":"2025","unstructured":"Tristancho-Bar\u00f3 A, L\u00f3pez-Calleja AI, Milagro A, Ariza M, Vi\u00f1eta V, Fortu\u00f1o B, L\u00f3pez C, Latorre-Mill\u00e1n M, Clusa L, Badenas-Alzugaray D, Mart\u00ednez R, Torres C, Rezusta A (2025b) Mechanisms of cefiderocol resistance in carbapenemase-producing enterobacterales: insights from comparative genomics. Antibiotics (Basel) 14:703. https:\/\/doi.org\/10.3390\/antibiotics14070703","journal-title":"Antibiotics (Basel)"},{"key":"13967_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005595","volume":"13","author":"RR Wick","year":"2017","unstructured":"Wick RR, Judd LM, Gorrie CL, Holt KE (2017) Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. https:\/\/doi.org\/10.1371\/journal.pcbi.1005595","journal-title":"PLoS Comput Biol"},{"key":"13967_CR64","unstructured":"Wick RR Filtlong: quality filtering tool for long reads (https:\/\/github.com\/rrwick\/filtlong) accessed 1 Oct 2025"},{"key":"13967_CR65","volume-title":"WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance, 1st ed. World Health Organization, Geneva","edition":"1st ed"},{"key":"13967_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40121-020-00286-6","volume":"9","author":"JY Wu","year":"2020","unstructured":"Wu JY, Srinivas P, Pogue JM (2020) Cefiderocol: a novel agent for the management of multidrug-resistant gram-negative organisms. Infect Dis Ther 9:17\u201340. https:\/\/doi.org\/10.1007\/s40121-020-00286-6","journal-title":"Infect Dis Ther"},{"key":"13967_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X (2017) Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 16:18. https:\/\/doi.org\/10.1186\/s12941-017-0191-3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"13967_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2022.115651","volume":"103","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Neidig N, Chu T-Y, Divoky C, Carpenter J, Lee-Hsiao C, Threatt H, Sultana R, Bush K (2022) In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates. Diagn Microbiol Infect Dis 103:115651. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115651","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13967-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13967-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13967-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:07:59Z","timestamp":1792541279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13967-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13967"],"URL":"https:\/\/doi.org\/10.1007\/s00253-026-13967-y","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the local institutional ethics committee \u201cComit\u00e9 de \u00c9tica de la Investigaci\u00f3n de la Comunidad Aut\u00f3noma de Arag\u00f3n (CEICA)\u201d, with protocol code PI25-121, and approval date 09 April 2025, in record no. 07\/2025. The study was conducted in accordance with local regulations (Spain), including compliance with the requirements of Law 14\/2007, of 3 July, on Biomedical Research, and the applicable ethical principles.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Exemption of informed consent for the collection of retrospective data was accepted by the local institutional ethics committee \u201cComit\u00e9 de \u00c9tica de la Investigaci\u00f3n de la Comunidad Aut\u00f3noma de Arag\u00f3n (CEICA)\u201d protocol code PI25\/121, and approval date 09 April 2025, in record no. 07\/2025.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"315"}}